GM’s 2025 EV production capacity target in doubt after Barra comments

GM’s 2025 EV production capacity target in doubt after Barra comments


GM CEO and Chair Mary Barra speaks during an “EV Day” on March 4, 2020, at the company’s tech and design campus in Warren, Michigan, a suburb of Detroit.

GM

General Motors‘ goal of being capable of producing 1 million all-electric vehicles in North America by the end of 2025 in heavily in doubt, following comments Monday by CEO Mary Barra.

The production capacity target for next year was one of the last EV targets the automaker hadn’t lowered or withdrawn as demand for EVs has not materialized as quickly as many companies such as GM previously expected.

“We won’t get to a million just because the market is not developing, but it will get there,” Barra said Monday at a virtual CNBC CEO Council event. “We’re going to be guided by the customer.”

For more than two years, GM has said it would have production capacity of 1 million in EVs in each China and North America by 2025. Even after it changed or withdrew several EV targets and product plans in the last year, the company continued to say it would install the North American capacity for EVs.

A GM spokesman initially said Barra did not say the company wouldn’t meet the production capacity target. He referenced the question was about producing 1 million EVs, which was not the goal.

The spokesman later said the company would no longer reiterate the EV production capacity plans for 2025. The company has continually said its EV plans will be flexible to meet demand.

More details about the automaker’s EV plans could come when GM reports second-quarter results on July 23.



Source

FDA fast-tracks psychedelic drug research following Trump executive order
Business

FDA fast-tracks psychedelic drug research following Trump executive order

FILE PHOTO: Psilocybin or “magic mushrooms” are seen in an undated photo provided by the U.S. Drug Enforcement Agency (DEA) in Washington, U.S. May 7, 2019. DEA | Reuters The U.S. Food and Drug Administration on Friday announced a series of measures aimed at accelerating the development of psychedelic treatments for serious mental illness. That […]

Read More
New York’s pied-a-terre tax sets up legal fight over values
Business

New York’s pied-a-terre tax sets up legal fight over values

A version of this article first appeared in CNBC’s Inside Wealth newsletter with Robert Frank, a weekly guide to the high-net-worth investor and consumer. Sign up to receive future editions, straight to your inbox. New York’s proposed tax on second homes worth more than $5 million is likely to spark costly legal battles over how to value […]

Read More
Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More